Intracellular Delivery of the p38 Mitogen-Activated Protein Kinase Inhibitor SB202190 [4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole] in Renal Tubular Cells: A Novel Strategy to Treat Renal Fibrosis

• Autores: M. Sandovici, J. Prakash
• Localización: Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, Vol. 319, Nº. 1, 2006, págs. 8-19
• Idioma: inglés
• Texto completo no disponible (Saber más ...)